Kindred Biosciences, Inc.KINNASDAQ
LOADING
|||
Cash Generation Expanding
Trending higher, above historical average, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-13.49M
↑ 48% above average
Average (8y)
$-25.81M
Historical baseline
Range
High:$-62000.00
Low:$-64.77M
CAGR
+96.0%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2020 | $-13.49M | +79.2% |
| 2019 | $-64.77M | -9.9% |
| 2018 | $-58.95M | -112.1% |
| 2017 | $-27.80M | -40.9% |
| 2016 | $-19.73M | +16.0% |
| 2015 | $-23.49M | -5.0% |
| 2014 | $-22.37M | -1309.0% |
| 2013 | $-1.59M | -2461.3% |
| 2012 | $-62000.00 | - |